a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WBELX | 9.28 | -0.02 | -0.22% |
William Blair Emerging Mkts Ldrs I | |||
FTASX | 28.49 | -0.26 | -0.90% |
Fidelity Advisor Asset Manager 70% M | |||
NUGCX | 36.48 | -0.37 | -1.00% |
Nuveen Global Dividend Growth C | |||
FHJUX | 35.41 | -0.43 | -1.20% |
Fidelity Advisor Europe A | |||
JGIRX | 87.30 | -1.79 | -2.01% |
JPMorgan U.S. GARP Equity R5 |
A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.
Ticker / NAME | Correlation To PRQR | 1D Price Change % | ||
---|---|---|---|---|
PRQR | 100% | -3.29% | ||
KRRO - PRQR | 49% Loosely correlated | -4.31% | ||
ATNF - PRQR | 47% Loosely correlated | -6.72% | ||
WVE - PRQR | 44% Loosely correlated | -8.87% | ||
ENVB - PRQR | 43% Loosely correlated | -8.06% | ||
LOGC - PRQR | 32% Poorly correlated | +1.67% | ||
More |